Ontology highlight
ABSTRACT: Background
AIDS Clinical Trial Group 5199 compared neurological and neuropsychological test performance of human immunodeficiency virus type 1 (HIV-1)-infected participants in resource-limited settings treated with 3 World Health Organization-recommended antiretroviral (ART) regimens. We investigated the impact of tuberculosis (TB) on neurological and neuropsychological outcomes.Methods
Standardized neurological and neuropsychological examinations were administered every 24 weeks. Generalized estimating equation models assessed the association between TB and neurological/neuropsychological performance.Results
Characteristics of the 860 participants at baseline were as follows: 53% female, 49% African; median age, 34 years; CD4 count, 173 cells/μL; and plasma HIV-1 RNA, 5.0 log copies/mL. At baseline, there were 36 cases of pulmonary, 9 cases of extrapulmonary, and 1 case of central nervous system (CNS) TB. Over the 192 weeks of follow-up, there were 55 observations of pulmonary TB in 52 persons, 26 observations of extrapulmonary TB in 25 persons, and 3 observations of CNS TB in 2 persons. Prevalence of TB decreased with ART initiation and follow-up. Those with TB coinfection had significantly poorer performance on grooved pegboard (P < .001) and fingertapping nondominant hand (P < .01). TB was associated with diffuse CNS disease (P < .05). Furthermore, those with TB had 9.27 times (P < .001) higher odds of reporting decreased quality of life, and had 8.02 times (P = .0005) higher odds of loss of productivity.Conclusions
TB coinfection was associated with poorer neuropsychological functioning, particularly the fine motor skills, and had a substantial impact on functional ability and quality of life.Clinical trials registration
NCT00096824.
SUBMITTER: Robertson KR
PROVIDER: S-EPMC6495021 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
Robertson Kevin R KR Oladeji Bibilola B Jiang Hongyu H Kumwenda Johnstone J Supparatpinyo Khuanchai K Campbell Thomas B TB Hakim James J Tripathy Srikanth S Hosseinipour Mina C MC Marra Christina M CM Kumarasamy Nagalingeswaran N Evans Scott S Vecchio Alyssa A La Rosa Alberto A Santos Breno B Silva Marcus T MT Montano Sylvia S Kanyama Cecilia C Firnhaber Cindy C Price Richard R Marcus Cheryl C Berzins Baida B Masih Reena R Lalloo Umesh U Sanne Ian I Yosief Sarah S Walawander Ann A Nair Aspara A Sacktor Ned N Hall Colin C
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20190501 10
<h4>Background</h4>AIDS Clinical Trial Group 5199 compared neurological and neuropsychological test performance of human immunodeficiency virus type 1 (HIV-1)-infected participants in resource-limited settings treated with 3 World Health Organization-recommended antiretroviral (ART) regimens. We investigated the impact of tuberculosis (TB) on neurological and neuropsychological outcomes.<h4>Methods</h4>Standardized neurological and neuropsychological examinations were administered every 24 weeks ...[more]